image
ARS Pharmaceuticals, Inc. SPRY
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 15.8
-0.691 %
$ 1.55 B
Market Cap
-98.75
P/E
Price Target Average
47.68%
Revenue Forecast Estimate
66.14%
EBIT Estimate
--243.41%
Net Income Estimate
127.37%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets ARS Pharmaceuticals, Inc.
image
Wall Street analysts predict an average 1-year price target for SPRY of $23.3 , with forecasts ranging from a low of $18 to a high of $30 .
SPRY Lowest Price Target Wall Street Target
18 USD 13.92%
SPRY Average Price Target Wall Street Target
23.3 USD 47.68%
SPRY Highest Price Target Wall Street Target
30 USD 89.87%
Price
Max Price Target
Min Price Target
Average Price Target
3030252520201515101055Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
REVENUE FORECAST

Revenue Forecast Chart SPRY

image
$700.0m$700.0m$600.0m$600.0m$500.0m$500.0m$400.0m$400.0m$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.02022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart SPRY

image
$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)($300.0m)($300.0m)($350.0m)($350.0m)($400.0m)($400.0m)($450.0m)($450.0m)2022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart SPRY

image
$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)2022202220232023202420242025202520262026202720272028202820292029